IL1B and ocular melanoma: DEX at a dose of 0.5 or 1 mg/kg reduced the cytokine levels of TNF-α (Fig 3A, p < 0.05) and IL-1β (Fig 3B, p < 0.05), compared to the 5-FU group (hamsters with OM and without treatment).